Company intelligence
Conexeu Sciences Inc.
Architecting Bioregeneration™
Biotechnology Research
Reno, US
14 employees
Founded 2023
2 public signals
About Conexeu Sciences Inc.
Conexeu Sciences is committed to advancing the science of tissue repair and regeneration. Our collagen-based ECM medical device candidate in preclinical development, CXU™, is designed to conform, integrate and support a more regenerative healing environment. It’s what we call, Architecting Bioregeneration ™. Important Notice: CXU™ is a medical device candidate in preclinical development and is not cleared or approved for marketing in the United States or any other jurisdiction. Safety and effectiveness have not been established.
Verified activity
Signals from Conexeu Sciences Inc.
2 published signals
Presence & Recognition
Conexeu Sciences Inc. participated in investor and industry conferences during September and October 2026 to engage with stakeholders and analysts.
Reported by Conexeu Sciences Inc.
Legal & Regulatory
Conexeu Sciences Inc. announced that B.R.E.A.S.T. and CXU are investigational device candidates, neither of which has been cleared or approved by the FDA for breast reconstruction or any other use.
Reported by Conexeu Sciences Inc.